Development of novel and effective therapeutics for treating various cancers is probably the
most congested and challenging enterprise of pharmaceutical companies. Diverse drugs …

Background: The predictive roles of diabetes in the prognosis of many types of cancer have
been well studied, but its role in predicting the prognosis of cervical cancer is still …

Aim: We aimed to estimate the disease burden and risk factors attributable to ovarian
cancer, and epidemiological trends at global, regional, and national levels. Methods: We …

Epidemiologic evidence regarding association of ovarian cancer risk with blood lipid level
and hyperlipidemia is inconsistent. We aimed to synthesize available epidemiologic studies …

Objectives Diabetes mellitus (DM) is associated with an elevated risk of various cancers,
including colorectal cancer (CRC). Similarly, pre-existing DM may also influence prognosis …

Background Diabetes mellitus (DM) is associated with poorer outcomes in some cancers. Its
effect on ovarian cancer is less clear. We consider the effect of DM on overall survival (OS) …

Background. Previous observational studies and meta‐analysis suggested a possible
association between metformin use and reduced mortality in women with ovarian cancer …

Ovarian cancer is the leading cause of death of all gynaecological cancers. To date, there is
no reliable, specific screening procedure for detecting ovarian cancer. The risk factors of …

Objective Evaluate the association between metformin and survival in women with Type 2
diabetes (T2DM) and breast, endometrial and ovarian cancer—3 hormonally mediated …

Background Ovarian cancer is one of the most common female malignancies worldwide,
and metabolic factors, such as hyperglycemia, are becoming potential risk factors. This study …